Seelos Therapeutics, Inc.
SEEL · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$38 | -$74 | -$66 | -$19 |
| Dep. & Amort. | $0 | $0 | $2 | $0 |
| Deferred Tax | $0 | $0 | -$2 | -$0 |
| Stock-Based Comp. | $4 | $5 | $8 | $2 |
| Change in WC | $12 | $3 | -$1 | -$5 |
| Other Non-Cash | -$2 | $4 | $10 | $1 |
| Operating Cash Flow | -$24 | -$62 | -$49 | -$21 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $6 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $6 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$8 | -$2 | -$14 | $0 |
| Stock Issued | $20 | $0 | $118 | $26 |
| Stock Repurch. | -$1 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | $7 | $0 |
| Financing Cash Flow | $11 | -$2 | $112 | $26 |
| Forex Effect | $0 | $0 | $0 | -$6 |
| Net Chg. in Cash | -$13 | -$63 | $63 | $5 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $16 | $79 | $16 | $10 |
| End Cash | $3 | $16 | $79 | $16 |
| Free Cash Flow | -$24 | -$62 | -$49 | -$21 |